As of 2025-12-18, the EV/EBITDA ratio of Rapt Therapeutics Inc (RAPT) is -8.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAPT's latest enterprise value is 881.49 mil USD. RAPT's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above RAPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-12-15 | -8.19 |
| 2025-12-12 | -9.11 |
| 2025-12-11 | -8.72 |
| 2025-12-10 | -9.07 |
| 2025-12-09 | -8.73 |
| 2025-12-08 | -8.64 |
| 2025-12-05 | -8.51 |
| 2025-12-04 | -8.51 |
| 2025-12-03 | -7.90 |
| 2025-12-02 | -7.96 |
| 2025-12-01 | -7.75 |
| 2025-11-28 | -8.34 |
| 2025-11-26 | -8.20 |
| 2025-11-25 | -7.36 |
| 2025-11-24 | -7.14 |
| 2025-11-21 | -6.61 |
| 2025-11-20 | -6.66 |
| 2025-11-19 | -6.93 |
| 2025-11-18 | -6.92 |
| 2025-11-17 | -7.02 |
| 2025-11-14 | -7.07 |
| 2025-11-13 | -6.80 |
| 2025-11-12 | -7.21 |
| 2025-11-11 | -7.23 |
| 2025-11-10 | -7.11 |
| 2025-11-07 | -7.07 |
| 2025-11-06 | -7.12 |
| 2025-11-05 | -6.92 |
| 2025-11-04 | -6.98 |
| 2025-11-03 | -7.20 |
| 2025-10-31 | -7.42 |
| 2025-10-30 | -7.29 |
| 2025-10-29 | -7.31 |
| 2025-10-28 | -7.40 |
| 2025-10-27 | -7.39 |
| 2025-10-24 | -7.24 |
| 2025-10-23 | -7.36 |
| 2025-10-22 | -7.36 |
| 2025-10-21 | -8.27 |
| 2025-10-20 | -8.31 |
| 2025-10-17 | -7.19 |
| 2025-10-16 | -7.09 |
| 2025-10-15 | -6.60 |
| 2025-10-14 | -6.08 |
| 2025-10-13 | -6.43 |
| 2025-10-10 | -6.54 |
| 2025-10-09 | -7.37 |
| 2025-10-08 | -7.22 |
| 2025-10-07 | -7.11 |
| 2025-10-06 | -7.33 |